Frazier Life Sciences Closes $138M IPO

The SPAC in its latest filing said the $138 million raaise includes a $5 million PIPE.

Frazier’s sponsor is committed to purchasing another $25 million in a private placement at the time of any acquisition.  

The biotech SPAC trades on the Nasdaq under FLACU. Read more.

Total
0
Shares
Related Posts